Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer

Hongxin Cao; Wei Dong; Hongchang Shen; Jun Xu; Linhai Zhu; Qi Liu; Jiajun Du

doi:10.1371/journal.pone.0135844

Loading metrics

Open Access

Peer-reviewed

Research Article

Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer

Hongxin Cao ,

Contributed equally to this work with: Hongxin Cao, Wei Dong

Affiliation Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China
⨯
Wei Dong ,

Contributed equally to this work with: Hongxin Cao, Wei Dong

Affiliations Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China, Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China
⨯
Hongchang Shen,

Affiliation Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China
⨯
Jun Xu,

Affiliation Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China
⨯
Linhai Zhu,

Affiliation Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China
⨯
Qi Liu ,

* E-mail: jiajundusdu@gmail.com

Affiliation Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China
⨯
Jiajun Du

* E-mail: jiajundusdu@gmail.com

Affiliations Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China, Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China
⨯

Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer

Hongxin Cao,
Wei Dong,
Hongchang Shen,
Jun Xu,
Linhai Zhu,
Qi Liu,
Jiajun Du

Published: August 19, 2015
https://doi.org/10.1371/journal.pone.0135844

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Small cell lung cancer
Is the Subject Area "Small cell lung cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
ERK signaling cascade
Is the Subject Area "ERK signaling cascade" applicable to this article?

Thanks for your feedback.
Signal inhibition
Is the Subject Area "Signal inhibition" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Clinical trials (cancer treatment)
Is the Subject Area "Clinical trials (cancer treatment)" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.